|
Volumn 6, Issue 10, 2009, Pages 553-
|
The Holy Grail of biomarkers
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CA 125 ANTIGEN;
CEDIRANIB;
CHORIONIC GONADOTROPIN;
PROSTATE SPECIFIC ANTIGEN;
CANCER RESEARCH;
CANCER SURVIVAL;
DISEASE MARKER;
EDITORIAL;
GENETIC EPIGENESIS;
GLIOBLASTOMA;
HUMAN;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PUBLICATION;
RECURRENT CANCER;
RESEARCH PRIORITY;
SENSITIVITY AND SPECIFICITY;
BIOMEDICAL RESEARCH;
CHORIOCARCINOMA;
CHORIONIC GONADOTROPIN;
FEMALE;
HUMANS;
MALE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 70349765931
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2009.145 Document Type: Editorial |
Times cited : (5)
|
References (0)
|